This story originally ran on Sept. 14.
Swedish protein detection and analysis firm Olink Bioscience and its sister company, Olink Genomics, today announced their participation in a project to improve the survival rate of patients with colorectal cancer.
The project, called "Companion Diagnostics Initiative" is financed by the Swedish Governmental Agency for Innovation Systems. The amount of funding was not disclosed. Mats Nilsson, a professor in genetics and pathology at Uppsala University is coordinating the project.